| P2093 | author name string | Ummugulsum Bayraktutan | |
| | Bulent Aydinli | |
| | Suat Eren | |
| | Berhan Pirimoglu | |
| | Hayri Ogul | |
| | Gurkan Ozturk | |
| | Mecit Kantarcı | |
| | Nevzat Karabulut | |
| | Sinan Yilmaz | |
| | Yesim Kizrak | |
| P2860 | cites work | Contrast-enhanced MR cholangiography (MRCP) with GD-EOB-DTPA in evaluating biliary complications after surgery | Q82154281 |
| | New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI | Q82694201 |
| | Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients | Q82917220 |
| | Gadoxetic acid disodium-enhanced magnetic resonance imaging for biliary and vascular evaluations in preoperative living liver donors: comparison with gadobenate dimeglumine-enhanced MRI | Q83015109 |
| | Staging of colorectal liver metastases after preoperative chemotherapy. Diffusion-weighted imaging in combination with Gd-EOB-DTPA MRI sequences increases sensitivity and diagnostic accuracy | Q84971980 |
| | Confident diagnosis of bronchobiliary fistula using contrast-enhanced magnetic resonance cholangiography | Q33945938 |
| | Diagnosis of Peritoneal Metastases with Abdominal Malignancies: Role of ADC Measurement on Diffusion Weighted MRI. | Q34666643 |
| | Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment | Q34699560 |
| | Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications | Q35676335 |
| | Contrast-enhanced magnetic resonance cholangiography using mangafodipir compared with standard T2W MRC sequences: a pictorial essay. | Q35843337 |
| | Functional MR cholangiography: diagnosis of functional abnormalities of the gallbladder and biliary tree | Q36108206 |
| | MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisation | Q36201171 |
| | CT and MR cholangiography: advantages and pitfalls in perioperative evaluation of biliary tree. | Q36326150 |
| | Contrast-enhanced MR cholangiography: comparison of Gd-EOB-DTPA and Mn-DPDP in healthy volunteers | Q36365414 |
| | MR contrast agents for liver imaging: what, when, how. | Q36652700 |
| | Classification of iatrogenic bile duct injury. | Q36952927 |
| | Vascular and biliary variants in the liver: implications for liver surgery | Q37113206 |
| | Laparoscopic cholecystectomy: postoperative imaging | Q37248247 |
| | Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree | Q39922989 |
| | An analysis of the problem of biliary injury during laparoscopic cholecystectomy. | Q40655269 |
| | Biliary MR imaging with Gd-EOB-DTPA and its clinical applications | Q43230364 |
| | Contrast-enhanced magnetic resonance cholangiography versus heavily T2-weighted magnetic resonance cholangiography | Q43770655 |
| | Using contrast-enhanced MR cholangiography with IV mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after cholecystectomy: a prospective study of 11 patients | Q44071959 |
| | Functional magnetic resonance cholangiography (fMRC) of the gallbladder and biliary tree with contrast-enhanced magnetic resonance cholangiography | Q44595938 |
| | Orthotopic liver transplantation: evaluation with MR cholangiography | Q44861314 |
| | Bile duct leaks after laparoscopic cholecystectomy: value of contrast-enhanced MRCP. | Q45249016 |
| | Visualization of the biliary tract using gadobenate dimeglumine: preliminary findings | Q46731300 |
| | Contrast-enhanced magnetic resonance cholangiography using gadolinium-EOB-DTPA. Preliminary experience and clinical applications | Q46927095 |
| | What role can endoscopy play in the management of biliary complications after laparoscopic cholecystectomy? | Q50156338 |
| | Value of MR cholangiography in patients with iatrogenic bile duct injury after cholecystectomy | Q50159367 |
| | Fistulous communication between a hepatic hydatid cyst and the gallbladder: diagnosis with MR cholangiopancreatography | Q50166279 |
| | Gadoxetate disodium-enhanced magnetic resonance cholangiography for the noninvasive detection of an active bile duct leak after laparoscopic cholecystectomy | Q50171379 |
| | Gd-EOB-DTPA enhanced MR imaging: evaluation of biliary and renal excretion in normal and cirrhotic livers. | Q53270569 |
| | Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects. | Q53485824 |
| | Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. | Q53648472 |
| | MR cholangiography in the examination of patients with biliary-enteric anastomoses | Q57944438 |
| | Rupture of echinococcal cysts: diagnosis, classification, and clinical implications | Q68857976 |
| | Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation | Q72989307 |
| | Gadobenate dimeglumine-enhanced liver MRI as the sole preoperative imaging technique: a prospective study of living liver donors | Q79288423 |
| | Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions | Q80143855 |
| | Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma | Q80965276 |
| | Contrast agents for MR imaging of the liver | Q81055636 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 2.5 Generic | Q19113746 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2713-2722 | |
| P577 | publication date | 2013-05-22 | |
| P1433 | published in | European Radiology | Q5413071 |
| P1476 | title | Non-invasive detection of biliary leaks using Gd-EOB-DTPA-enhanced MR cholangiography: comparison with T2-weighted MR cholangiography | |
| P478 | volume | 23 | |